AS1411 aptamer (ASA) is the most common aptamer that has been investigated in cancer treatment because it binds to nucleolin overexpressed on plasma membranes of many cancer cells (Bates et al., 1999). The gene discussed is NUCLEOLIN; the disease is cancer.